<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2005-06-13" updated="2020-01-02">
  <drugbank-id primary="true">DB00566</drugbank-id>
  <drugbank-id>APRD01236</drugbank-id>
  <name>Succimer</name>
  <description>A mercaptodicarboxylic acid used as an antidote to heavy metal poisoning because it forms strong chelates with them.</description>
  <cas-number>304-55-2</cas-number>
  <unii>DX1U2629QE</unii>
  <average-mass>182.21</average-mass>
  <monoisotopic-mass>181.970751021</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <ref-id>A868</ref-id>
        <pubmed-id>9630737</pubmed-id>
        <citation>Miller AL: Dimercaptosuccinic acid (DMSA), a non-toxic, water-soluble treatment for heavy metal toxicity. Altern Med Rev. 1998 Jun;3(3):199-207.</citation>
      </article>
      <article>
        <ref-id>A869</ref-id>
        <pubmed-id>7741240</pubmed-id>
        <citation>Aaseth J, Jacobsen D, Andersen O, Wickstrom E: Treatment of mercury and lead poisonings with dimercaptosuccinic acid and sodium dimercaptopropanesulfonate. A review. Analyst. 1995 Mar;120(3):853-4.</citation>
      </article>
      <article>
        <ref-id>A870</ref-id>
        <pubmed-id>1663439</pubmed-id>
        <citation>Mann KV, Travers JD: Succimer, an oral lead chelator. Clin Pharm. 1991 Dec;10(12):914-22.</citation>
      </article>
    </articles>
    <textbooks/>
    <links/>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication>For the treatment of lead poisoning in pediatric patients with blood lead levels above 45 &amp;micro;g/dL. May also be used to treat mercury or arsenic poisoning.</indication>
  <pharmacodynamics>Succimer is an orally active, heavy metal chelating agent. It forms water soluble chelates and, consequently, increases the urinary excretion of lead. Succimer is not to be used for prophylaxis of lead poisoning in a lead-containing environment. In addition, the use of succimer should always be accompanied by identification and removal of the source of the lead exposure.</pharmacodynamics>
  <mechanism-of-action>Succimer is a heavy metal chelator. It binds with high specificity to ions of lead in the blood to form a water-soluble complex that is subsequently excreted by the kidneys. Succimer can also chelate mercury, cadmium, and arsenic in this manner.</mechanism-of-action>
  <toxicity>Oral LD&lt;sub&gt;50&lt;/sub&gt; in mice is over 5011 mg/kg. Doses of 2300 mg/kg in the rat and 2400 mg/kg in the mouse produced ataxia, convulsions, labored respiration and frequently death. No case of overdosage has been reported in humans. Limited data indicate that succimer is dialyzable.</toxicity>
  <metabolism>Chemical analysis of succimer and its metabolites (primarily mixed disulfides of L-cysteine) in the urine showed that succimer was rapidly and extensively metabolized however the specific site of biotransformation is not known.</metabolism>
  <absorption>Rapid but variable.</absorption>
  <half-life>48 hours</half-life>
  <protein-binding/>
  <route-of-elimination>Unabsorbed drug is excreted primarily in feces and absorbed drug is excreted primarily in the urine as metabolites.</route-of-elimination>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of organic compounds known as thia fatty acids. These are fatty acid derivatives obtained by insertion of a sulfur atom at specific positions in the chain.</description>
    <direct-parent>Thia fatty acids</direct-parent>
    <kingdom>Organic compounds</kingdom>
    <superclass>Lipids and lipid-like molecules</superclass>
    <class>Fatty Acyls</class>
    <subclass>Fatty acids and conjugates</subclass>
    <alternative-parent>Alkylthiols</alternative-parent>
    <alternative-parent>Carbonyl compounds</alternative-parent>
    <alternative-parent>Dicarboxylic acids and derivatives</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>Organic oxides</alternative-parent>
    <alternative-parent>alpha-Mercaptocarboxylic acids</alternative-parent>
    <substituent>2-mercaptocarboxylic acid</substituent>
    <substituent>Aliphatic acyclic compound</substituent>
    <substituent>Alkylthiol</substituent>
    <substituent>Carbonyl group</substituent>
    <substituent>Carboxylic acid</substituent>
    <substituent>Carboxylic acid derivative</substituent>
    <substituent>Dicarboxylic acid or derivatives</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>Organic oxide</substituent>
    <substituent>Organic oxygen compound</substituent>
    <substituent>Organooxygen compound</substituent>
    <substituent>Organosulfur compound</substituent>
    <substituent>Thia fatty acid</substituent>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="english" coder="">DIM-SA</synonym>
    <synonym language="english" coder="">DMS</synonym>
    <synonym language="english" coder="">DMS-A</synonym>
    <synonym language="english" coder="">DMSA</synonym>
    <synonym language="german" coder="">meso-2,3-Dimercaptobernsteinsäure</synonym>
    <synonym language="english" coder="">meso-2,3-dimercaptosuccinic acid</synonym>
    <synonym language="english" coder="">meso-dimercaptosuccinic acid</synonym>
    <synonym language="english" coder="inn/usan">Succimer</synonym>
    <synonym language="spanish" coder="inn">succimero</synonym>
  </synonyms>
  <products>
    <product>
      <name>Chemet</name>
      <labeller>Lundbeck Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>67386-201</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1991-01-30</started-marketing-on>
      <ended-marketing-on>2013-04-15</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength>100 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>NDA019998</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Chemet</name>
      <labeller>RECORDATI RARE DISEASES, INC.</labeller>
      <ndc-id/>
      <ndc-product-code>55292-201</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-08-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength>100 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>NDA019998</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Chemet</name>
      <ingredients>Succimer</ingredients>
    </mixture>
    <mixture>
      <name>Chemet</name>
      <ingredients>Succimer</ingredients>
    </mixture>
  </mixtures>
  <packagers>
    <packager>
      <name>GE Healthcare Inc.</name>
      <url>http://www.gehealthcare.com</url>
    </packager>
    <packager>
      <name>Lundbeck Inc.</name>
      <url>http://www.lundbeckinc.com</url>
    </packager>
    <packager>
      <name>Medi-Physics Inc.</name>
      <url/>
    </packager>
    <packager>
      <name>Medisca Inc.</name>
      <url>http://www.medisca.com</url>
    </packager>
    <packager>
      <name>Sanofi-Aventis Inc.</name>
      <url>http://www.sanofi-aventis.com</url>
    </packager>
    <packager>
      <name>Schwarz Pharma Inc.</name>
      <url/>
    </packager>
  </packagers>
  <manufacturers>
    <manufacturer generic="false" url="">Lundbeck inc</manufacturer>
    <manufacturer generic="false" url="">Ge healthcare</manufacturer>
  </manufacturers>
  <prices>
    <price>
      <description>Chemet 100 mg capsule</description>
      <cost currency="USD">8.6</cost>
      <unit>capsule</unit>
    </price>
    <price>
      <description>Dmsa powder</description>
      <cost currency="USD">15.61</cost>
      <unit>g</unit>
    </price>
  </prices>
  <categories>
    <category>
      <category>Acids, Acyclic</category>
      <mesh-id>D000144</mesh-id>
    </category>
    <category>
      <category>Antidotes</category>
      <mesh-id>D000931</mesh-id>
    </category>
    <category>
      <category>Chelating Agents</category>
      <mesh-id>D002614</mesh-id>
    </category>
    <category>
      <category>Compounds used in a research, industrial, or household setting</category>
      <mesh-id>D020313</mesh-id>
    </category>
    <category>
      <category>Dicarboxylic Acids</category>
      <mesh-id>D003998</mesh-id>
    </category>
    <category>
      <category>Lead Chelating Activity</category>
      <mesh-id/>
    </category>
    <category>
      <category>Lead Chelator</category>
      <mesh-id/>
    </category>
    <category>
      <category>Protective Agents</category>
      <mesh-id>D020011</mesh-id>
    </category>
    <category>
      <category>Sequestering Agents</category>
      <mesh-id>D064449</mesh-id>
    </category>
    <category>
      <category>Succinates</category>
      <mesh-id>D013386</mesh-id>
    </category>
    <category>
      <category>Sulfhydryl Compounds</category>
      <mesh-id>D013438</mesh-id>
    </category>
    <category>
      <category>Sulfur Compounds</category>
      <mesh-id>D013457</mesh-id>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Capsule</form>
      <route>Oral</route>
      <strength>100 mg/1</strength>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries/>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB00566.pdf?1265922739</msds>
  <patents/>
  <food-interactions/>
  <drug-interactions>
    <drug-interaction>
      <drugbank-id>DB09139</drugbank-id>
      <name>Technetium Tc-99m oxidronate</name>
      <description>Succimer may decrease effectiveness of Technetium Tc-99m oxidronate as a diagnostic agent.</description>
    </drug-interaction>
  </drug-interactions>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>0.56</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-1.9</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>2.43e+00 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>0.26</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>(2R,3S)-2,3-disulfanylbutanedioic acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>succimer</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>182.21</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>181.970751021</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>OC(=O)[C@@H](S)[C@@H](S)C(O)=O</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C4H6O4S2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C4H6O4S2/c5-3(6)1(9)2(10)4(7)8/h1-2,9-10H,(H,5,6)(H,7,8)/t1-,2+</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>ACTRVOBWPAIOHC-XIXRPRMCSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>74.6</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>38.47</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>15.45</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>4</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>4</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>3.37</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>-2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>Melting Point</kind>
      <value>193 °C</value>
      <source>PhysProp</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>-0.3</value>
      <source/>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>63623</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>2724354</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>46504680</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Compound</resource>
      <identifier>C07598</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Drug</resource>
      <identifier>D00572</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>2006502</identifier>
    </external-identifier>
    <external-identifier>
      <resource>BindingDB</resource>
      <identifier>50232640</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PharmGKB</resource>
      <identifier>PA451521</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Succimer</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL1201073</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links>
    <external-link>
      <resource>RxList</resource>
      <url>http://www.rxlist.com/chemet-drug.htm</url>
    </external-link>
    <external-link>
      <resource>Drugs.com</resource>
      <url>http://www.drugs.com/cdi/succimer.html</url>
    </external-link>
  </external-links>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target position="1">
      <id>BE0004808</id>
      <name>Lead</name>
      <organism>Humans</organism>
      <actions>
        <action>chelator</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A16993</ref-id>
            <pubmed-id>19663612</pubmed-id>
            <citation>Bradberry S, Vale A: Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning. Clin Toxicol (Phila). 2009 Aug;47(7):617-31. doi: 10.1080/15563650903174828.</citation>
          </article>
          <article>
            <ref-id>A16994</ref-id>
            <pubmed-id>17189579</pubmed-id>
            <citation>Gracia RC, Snodgrass WR: Lead toxicity and chelation therapy. Am J Health Syst Pharm. 2007 Jan 1;64(1):45-53.</citation>
          </article>
          <article>
            <ref-id>A868</ref-id>
            <pubmed-id>9630737</pubmed-id>
            <citation>Miller AL: Dimercaptosuccinic acid (DMSA), a non-toxic, water-soluble treatment for heavy metal toxicity. Altern Med Rev. 1998 Jun;3(3):199-207.</citation>
          </article>
          <article>
            <ref-id>A16995</ref-id>
            <pubmed-id>8249780</pubmed-id>
            <citation>Jorgensen FM: Succimer: the first approved oral lead chelator. Am Fam Physician. 1993 Dec;48(8):1496-502.</citation>
          </article>
          <article>
            <ref-id>A869</ref-id>
            <pubmed-id>7741240</pubmed-id>
            <citation>Aaseth J, Jacobsen D, Andersen O, Wickstrom E: Treatment of mercury and lead poisonings with dimercaptosuccinic acid and sodium dimercaptopropanesulfonate. A review. Analyst. 1995 Mar;120(3):853-4.</citation>
          </article>
          <article>
            <ref-id>A16996</ref-id>
            <pubmed-id>16305472</pubmed-id>
            <citation>Blanusa M, Varnai VM, Piasek M, Kostial K: Chelators as antidotes of metal toxicity: therapeutic and experimental aspects. Curr Med Chem. 2005;12(23):2771-94.</citation>
          </article>
          <article>
            <ref-id>A16997</ref-id>
            <pubmed-id>7716789</pubmed-id>
            <citation>Aposhian HV, Maiorino RM, Gonzalez-Ramirez D, Zuniga-Charles M, Xu Z, Hurlbut KM, Junco-Munoz P, Dart RC, Aposhian MM: Mobilization of heavy metals by newer, therapeutically useful chelating agents. Toxicology. 1995 Mar 31;97(1-3):23-38.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>yes</known-action>
    </target>
    <target position="2">
      <id>BE0004814</id>
      <name>Mercury</name>
      <organism>Humans</organism>
      <actions>
        <action>chelator</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A16998</ref-id>
            <pubmed-id>10742922</pubmed-id>
            <citation>Ozuah PO: Mercury poisoning. Curr Probl Pediatr. 2000 Mar;30(3):91-9.</citation>
          </article>
          <article>
            <ref-id>A868</ref-id>
            <pubmed-id>9630737</pubmed-id>
            <citation>Miller AL: Dimercaptosuccinic acid (DMSA), a non-toxic, water-soluble treatment for heavy metal toxicity. Altern Med Rev. 1998 Jun;3(3):199-207.</citation>
          </article>
          <article>
            <ref-id>A869</ref-id>
            <pubmed-id>7741240</pubmed-id>
            <citation>Aaseth J, Jacobsen D, Andersen O, Wickstrom E: Treatment of mercury and lead poisonings with dimercaptosuccinic acid and sodium dimercaptopropanesulfonate. A review. Analyst. 1995 Mar;120(3):853-4.</citation>
          </article>
          <article>
            <ref-id>A16996</ref-id>
            <pubmed-id>16305472</pubmed-id>
            <citation>Blanusa M, Varnai VM, Piasek M, Kostial K: Chelators as antidotes of metal toxicity: therapeutic and experimental aspects. Curr Med Chem. 2005;12(23):2771-94.</citation>
          </article>
          <article>
            <ref-id>A16997</ref-id>
            <pubmed-id>7716789</pubmed-id>
            <citation>Aposhian HV, Maiorino RM, Gonzalez-Ramirez D, Zuniga-Charles M, Xu Z, Hurlbut KM, Junco-Munoz P, Dart RC, Aposhian MM: Mobilization of heavy metals by newer, therapeutically useful chelating agents. Toxicology. 1995 Mar 31;97(1-3):23-38.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>yes</known-action>
    </target>
    <target position="3">
      <id>BE0004802</id>
      <name>Cadmium</name>
      <organism>Humans</organism>
      <actions>
        <action>chelator</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A868</ref-id>
            <pubmed-id>9630737</pubmed-id>
            <citation>Miller AL: Dimercaptosuccinic acid (DMSA), a non-toxic, water-soluble treatment for heavy metal toxicity. Altern Med Rev. 1998 Jun;3(3):199-207.</citation>
          </article>
          <article>
            <ref-id>A16996</ref-id>
            <pubmed-id>16305472</pubmed-id>
            <citation>Blanusa M, Varnai VM, Piasek M, Kostial K: Chelators as antidotes of metal toxicity: therapeutic and experimental aspects. Curr Med Chem. 2005;12(23):2771-94.</citation>
          </article>
          <article>
            <ref-id>A16997</ref-id>
            <pubmed-id>7716789</pubmed-id>
            <citation>Aposhian HV, Maiorino RM, Gonzalez-Ramirez D, Zuniga-Charles M, Xu Z, Hurlbut KM, Junco-Munoz P, Dart RC, Aposhian MM: Mobilization of heavy metals by newer, therapeutically useful chelating agents. Toxicology. 1995 Mar 31;97(1-3):23-38.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>yes</known-action>
    </target>
    <target position="4">
      <id>BE0004813</id>
      <name>Arsenic</name>
      <organism>Humans</organism>
      <actions>
        <action>chelator</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A868</ref-id>
            <pubmed-id>9630737</pubmed-id>
            <citation>Miller AL: Dimercaptosuccinic acid (DMSA), a non-toxic, water-soluble treatment for heavy metal toxicity. Altern Med Rev. 1998 Jun;3(3):199-207.</citation>
          </article>
          <article>
            <ref-id>A16996</ref-id>
            <pubmed-id>16305472</pubmed-id>
            <citation>Blanusa M, Varnai VM, Piasek M, Kostial K: Chelators as antidotes of metal toxicity: therapeutic and experimental aspects. Curr Med Chem. 2005;12(23):2771-94.</citation>
          </article>
          <article>
            <ref-id>A16997</ref-id>
            <pubmed-id>7716789</pubmed-id>
            <citation>Aposhian HV, Maiorino RM, Gonzalez-Ramirez D, Zuniga-Charles M, Xu Z, Hurlbut KM, Junco-Munoz P, Dart RC, Aposhian MM: Mobilization of heavy metals by newer, therapeutically useful chelating agents. Toxicology. 1995 Mar 31;97(1-3):23-38.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>yes</known-action>
    </target>
  </targets>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>